C Donadio Selected Research

calcium phosphate

2/2006

Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Donadio Research Topics

Disease

2	Hypoglycemia (Reactive Hypoglycemia) 04/2016 - 01/2015
2	Acute Kidney Injury (Acute Renal Failure) 04/2016 - 01/2015
2	Critical Illness (Critically Ill) 04/2016 - 01/2015
1	Hyperglycemia 01/2015
1	Insulin Resistance 01/2015
1	Sepsis (Septicemia) 01/2015
1	Papillomavirus Infections 02/2010
1	Infections 02/2010
1	Candidiasis (Moniliasis) 02/2010
1	Chronic Renal Insufficiency 03/2007
1	Bone Diseases (Bone Disease) 03/2007
1	Dyslipidemias (Dyslipidemia) 02/2006
1	Malnutrition (Nutritional Deficiencies) 02/2006
1	Anemia 02/2006
1	Hypertension (High Blood Pressure) 02/2006
1	Type 2 Diabetes Mellitus (MODY) 09/2005
1	Neutropenia 08/2001
1	Polycythemia (Erythrocytosis) 08/2001
1	Kidney Diseases (Kidney Disease) 05/2001
1	Renal Insufficiency (Renal Failure) 05/2001
1	Neoplasms (Cancer) 01/2000
1	Carcinoma (Carcinomatosis) 01/2000

Drug/Important Bio-Agent (IBA)

3	Blood Glucose (Blood Sugar)IBA 04/2016 - 09/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 09/2005
2	Proteins (Proteins, Gene)FDA Link 05/2001 - 01/2000
1	Hormones (Hormone)IBA 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	beta-GlucansIBA 02/2010
1	Biomarkers (Surrogate Marker)IBA 03/2007
1	Parathyroid Hormone (Parathormone)IBA 03/2007
1	calcium phosphateIBA 02/2006
1	Enalapril FDA LinkGeneric 08/2001
1	Pentetic Acid (DTPA)FDA LinkGeneric 05/2001
1	EpitopesIBA 01/2000
1	Keratin-19 (Keratin 19)IBA 01/2000
1	AntigensIBA 01/2000
1	Kazal Pancreatic Trypsin InhibitorIBA 01/2000
1	Tumor Biomarkers (Tumor Markers)IBA 01/2000
1	antigen CYFRA21.1IBA 01/2000
1	Tissue Polypeptide AntigenIBA 01/2000

Therapy/Procedure

2	Glycemic Control 04/2016 - 01/2015
2	Therapeutics 02/2010 - 02/2006
1	Aftercare (After-Treatment) 08/2001